tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Kinnate Biopharma downgraded to Market Perform from Outperform at William Blair

William Blair downgraded Kinnate Biopharma (KNTE) to Market Perform from Outperform after Kinnate announced an agreement to be acquired by Xoma Corporation (XOMA).

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

See today’s best-performing stocks on TipRanks >>

Read More on KNTE:

Disclaimer & DisclosureReport an Issue

1